Low expression of PRMT5 in peripheral blood may serve as a potential independent risk factor in assessments of the risk of stable CAD and AMI

BACKGROUND: Protein arginine methyltransferases (PRMTs) can catalyse the methylation of arginine and participate in many important cellular reaction processes. The purpose of this research is to determine whether the expression levels of the PRMT5 gene in peripheral blood can be used as a biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Buchuan, Liu, Qian, Yang, Liping, Yang, Yushuang, Liu, Dongna, Liu, Long, Meng, Fanbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357489/
https://www.ncbi.nlm.nih.gov/pubmed/30704408
http://dx.doi.org/10.1186/s12872-019-1008-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357489/
https://www.ncbi.nlm.nih.gov/pubmed/30704408
http://dx.doi.org/10.1186/s12872-019-1008-4

Ejemplares similares